PCVX R&D Expenses
Vaxcyte Inc · R&D Expenses
PCVX R&D Expenses
Latest reported$267.85Mperiod ending
PCVX Quarterly R&D Expenses ($12.63M → $267.85M)
Quarterly R&D Expenses
High-resolution chart · PNG
PCVX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 267,852,000 | |
| 312,779,000 | |
| 242,060,000 | |
| 209,933,000 | |
| 194,179,000 | |
| 148,134,000 | |
| 133,614,000 | |
| 116,936,000 | |
| 131,507,000 | |
| 94,587,000 | |
| 104,150,000 | |
| 97,421,000 | |
| 72,691,000 | |
| 58,080,000 | |
| 51,626,000 | |
| 47,679,000 | |
| 38,469,000 | |
| 31,678,000 | |
| 23,074,000 | |
| 20,428,000 | |
| 17,651,000 | |
| 17,258,000 | |
| 14,661,000 | |
| 16,410,000 | |
| 18,178,000 | |
| 24,315,000 | |
| 13,382,000 | |
| 9,630,000 | |
| 9,968,000 | |
| 12,628,000 |